News
Latest News
Our Recent Posts
Tight K e-bulletins
The Tight K trial is investigating maintenance of high-normal serum potassium for the prevention of dysrhythmias following coronary artery bypass graft surgery
Details
‘Her Life Matters’ Documentary is live
This documentary ‘Her Life Matters’ asks why each year, world-wide tens of thousands of mothers bleed to death needlessly – lives that could be saved by a single injection of an inexpensive generic drug called tranexamic acid. Tranexamic acid was invented sixty years ago to stop mothers from bleeding to death after childbirth. The Woman
Details
TXA Central
TXA Central collates information about clinical trial research conducted on Tranexamic Acid and is a resource for health professionals caring for patients with acute severe bleeding.
Details
WOMAN-PharmacoTXA Trial
The WOMAN-PharmacoTXA
trial investigates the intramuscular and oral solutions of TXA in women undergoing Caesarean Section with at least one known risk factor for PPH
WOMAN-2 Trial
The WOMAN-2 trial investigates Tranexamic Acid (TXA) for the prevention of postpartum bleeding in women with anaemia
Details
A CRASH-3 Trial Sub-Study Provides Evidence of TXA Benefit in TBI
Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a randomised trial
Details
Art for Maternal Health Awareness
Sculpture artist, Moira Purver was commissioned by the WOMAN trial to create this spectacular bronze statue that depicts a mother on her knees holding her new baby in her arms just after giving birth.
Details
World Day of Remembrance for Road Traffic Victims
The researchers call urgent TXA treatment of all trauma victims, ideally at the scene of the crash, could prevent over 100,000 premature deaths each year worldwide.
Details
Educational | Evidence Tranexamic Acid Saves Lives
This is an informative video showing the history and providing compelling evidence tranexamic acid, or TXA, saves lives.
Details
Tight K Trial is Recruiting!
TRIAL UPDATE (10/20): CONGRATULATIONS to the NHS Barts Health research team for recruiting their first patients into the TIGHTK Trial!
Details- 1
- 2